Health Matrix expands its public health digital portfolio offering for the Middle East’s healthcare sector with BlueDot

Health Matrix expands its public health digital portfolio offering for the Middle East’s healthcare sector with BlueDot

Riyadh-Saudi Arabia — In response to the healthcare transformation programs across the Middle East, Health Matrix, a leading digital health transformation enabler, is extending its public health digital offering through a strategic partnership agreement with BlueDot Inc., a leading organization that uses artificial and human intelligence to detect, assess, and respond to infectious disease threats worldwide.

BlueDot, a Toronto-based infectious disease intelligence company, has developed a machine learning-powered global early warning surveillance system for infectious diseases. Using human and artificial intelligence, BlueDot’s outbreak risk platform tracks over 150 infectious diseases globally in 130 languages around the clock, and anticipates their spread and impact. BlueDot was among the first in the world to identify the emerging risk from, and publish one of the first peer-reviewed scientific papers on, COVID-19, and delivers regular critical Insights to its partners and customers worldwide to mobilize timely, effective, efficient, coordinated, and measured responses. Since the pandemic, BlueDot has expanded its datasets, analysis, and forecasting capabilities to address the overall changing disease landscape.

The collaboration further expands BlueDot’s global presence in the Middle East, where the company will be able to support the region’s ability to respond to global outbreaks at the national and regional levels within both